Literature DB >> 30360719

Recent Advances in the System Biology-based Target Identification and Drug Discovery.

Brijesh Singh Yadav1, Vijay Tripathi2.   

Abstract

The enormous quantity of publicly available active chemical ligand and biological receptor data knowledge allows scientists to retreat several open questions by the analysis and systematic integration of these complex unique data. Systems biology plays a crucial role through the constructive alignment of bio-physiochemical monitoring of gene, protein along with metabolites from the complex data. Further, it integrates information within the data and responses (metabolic and signaling pathway) which lead to the formulation of computational models for the elucidation of structure and function of the molecular determinant. The system biology methods utilize big complex high throughput data for the identification of the whole drug target and for the mechanism of action to lead compound characterization. Nowadays, the system biology is one of the most popular approaches to characterize proteinligand interaction on a large scale and is vital to address a complex mode of the drug action to clinical indications. The network of protein-ligand interactions also reveals the correlation between molecular functions of the cell with their physiological processes which help to design safe and effective ligands for drug development. Here, we review recent attempts to apply system biology-based approaches with large-scale network analyses to predict novel interactions of ligand and targets. We also deliver an essential step involved in the discovery and development of such multi-target drugs by identifying the group of proteins targeted by a particular ligand, leading to innovation in therapeutic research. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Keywords:  Docking; Drug discovery; Ligand; Network; Protein-ligand interaction; System biology.

Mesh:

Substances:

Year:  2018        PMID: 30360719     DOI: 10.2174/1568026618666181025112344

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  7 in total

Review 1.  Molecular targets and system biology approaches for drug repurposing against SARS-CoV-2.

Authors:  Rahul Kunwar Singh; Brijesh Singh Yadav; Tribhuvan Mohan Mohapatra
Journal:  Bull Natl Res Cent       Date:  2020-11-19

2.  KRCC1: A potential therapeutic target in ovarian cancer.

Authors:  Shailendra Kumar Dhar Dwivedi; Khader Shameer; Anindya Dey; Soumyajit Banerjee Mustafi; Xunhao Xiong; Udayan Bhattacharya; Fiifi Neizer-Ashun; Geeta Rao; Yue Wang; Cristina Ivan; Da Yang; Joel T Dudley; Chao Xu; Jonathan D Wren; Priyabrata Mukherjee; Resham Bhattacharya
Journal:  FASEB J       Date:  2019-12-23       Impact factor: 5.191

3.  Induction of homeostatic biological parameters in reward deficiency as a function of an iron-free multi-nutrient complex: Promoting hemoglobinization, aerobic metabolism, viral immuno-competence, and neuroinflammatory regulation.

Authors:  Kenneth Blum; Bernard W Downs; Manashi Bagchi; Steve Kushner; Bruce S Morrison; Jeffrey Galvin; Kourtney Randsdorp; Justin Randsdorp; Rajendra D Badgaiyan; Eric R Braverman; Debasis Bagchi
Journal:  J Syst Integr Neurosci       Date:  2020-06-29

4.  STAT1: a novel candidate biomarker and potential therapeutic target of the recurrent aphthous stomatitis.

Authors:  Mingchen Cao; Lei Li; Long Xu; Mengxiang Fang; Xiaomin Xing; Changkai Zhou; Wei Ren; Longyuan Wang; Fanbo Jing
Journal:  BMC Oral Health       Date:  2021-10-14       Impact factor: 2.757

5.  Drug-Target Interaction Prediction Based on Multisource Information Weighted Fusion.

Authors:  Shuaiqi Liu; Jingjie An; Jie Zhao; Shuhuan Zhao; Hui Lv; ShuiHua Wang
Journal:  Contrast Media Mol Imaging       Date:  2021-11-24       Impact factor: 3.161

6.  Research on the Mechanism of Liuwei Dihuang Decoction for Osteoporosis Based on Systematic Biological Strategies.

Authors:  Zhi-Yong Long; Jia-Min Wu; Wang Xiang; Meng-Xia Yuan; Yong-He Wu; Jun Li; Gan-Peng Yu; Tiejun Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-22       Impact factor: 2.650

7.  Drug repurposing candidates to treat core symptoms in autism spectrum disorder.

Authors:  Elise Koch; Ditte Demontis
Journal:  Front Pharmacol       Date:  2022-09-12       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.